Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Healthtrust
Queensland Health
McKinsey
Mallinckrodt
US Department of Justice

Generated: August 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,487,005

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,487,005 protect, and when does it expire?

Patent 8,487,005 protects LYSTEDA and is included in one NDA.

This patent has eight patent family members in two countries.

Summary for Patent: 8,487,005
Title:Tranexamic acid formulations
Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
Inventor(s): Moore; Keith A. (Loveland, OH), Heasley; Ralph A. (Webster Grove, MO), Greiwe; Jeffrey S. (Ft. Thomas, KY), Facemire; John W. (Douglasville, GA), Modest; Jason D. (Minneapolis, MN)
Assignee: Ferring B.V. (NL)
Application Number:13/620,148
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,487,005
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 8,487,005

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ferring Pharms Inc LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes   Try a Free Trial   Try a Free Trial Y TREATMENT OF CYCLIC HEAVY MENSTRUAL BLEEDING   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 8,487,005

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 2008508275   Try a Free Trial
Japan 2008508276   Try a Free Trial
Japan 2011168596   Try a Free Trial
Japan 2014193878   Try a Free Trial
Japan 5000504   Try a Free Trial
Japan 5205053   Try a Free Trial
World Intellectual Property Organization (WIPO) 2006023000   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Harvard Business School
Daiichi Sankyo
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.